Implementation of a Psychoeducational Intervention in New Mothers
EQEP
Adaptation and Implementation of a Psychoeducational Intervention to Prevent Postpartum Depression and Anxiety Disorders in New Mothers
1 other identifier
interventional
400
1 country
2
Brief Summary
The goal of this clinical trial is to implement and examine the clinical effectiveness in a randomized study of the Catalan and Spanish versions of the culturally adapted "What Were We Thinking (WWWT)" psychoeducational intervention in primary care services, with the aim of preventing and reducing the prevalence of postpartum mental illness in new mothers. Additionally, the trial will assess the acceptability and accessibility of the intervention by families and professionals. Researchers will compare "Usual Care" (standard postnatal care provided by professionals from the Sexual and Reproductive Health Service) with "Intervention group" (usual care plus two psychoeducative intervention WWWT sessions) to see if the "WWWT intervention" is better than "Usual Care" at preventing postpartum depression and anxiety disorders in new mothers. Participants will:
- Take baseline questionnaires at 2-4 weeks postpartum
- Take usual care or usual care plus two psychoeducative intervention WWWT sessions within the first 6 weeks postpartum
- Take the same questionnaires used in baseline plus a semi-structured interview to diagnose major mental disorder (all participants) at 3 and 6 months follow-up
- Take a brief anonymous self-report survey (only those participants taking the WWWT intervention)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2024
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 15, 2024
CompletedFirst Posted
Study publicly available on registry
July 22, 2024
CompletedStudy Start
First participant enrolled
November 8, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2027
February 26, 2025
February 1, 2025
2.6 years
July 15, 2024
February 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Mental Disorders
The Mini-International Neuropsychiatric Interview (MINI) is a brief structured interview designed for the detection and diagnostic guidance of major Axis I psychiatric disorders as defined by the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) and the International Classification of Diseases, 10th Edition (ICD-10). It has an administration time of approximately 15 minutes and is divided into 16 modules, identified by letters, each corresponding to a diagnostic category.
3 and 6 months postpartum (follow-up)
Depressive symptoms
The Edinburgh Postnatal Depression Scale (EPDS) is a 10-item self-report questionnaire that is used as a screening instrument and for research purposes. Item scores are summed up to a total score (from 0 to 30 points), with higher scores indicating a higher depressive symptom burden. At a cutoff value of 11 (EPDS ≥ 11), the sensitivity of detecting a clinically significant depression is 0.79, the specificity is 0.95, and the positive predictive value is 0.63. The scale has a good internal consistency (Cronbach's α = 0.81).
Baseline, 3 and 6 months follow-up
Depressive symptoms
The Beck Depression Inventory (BDI-II) is a 21-item self-report instrument designed to assess the severity of depressive symptomatology. In each item, the person evaluated must select the phrase that best describes their condition over the past two weeks from a list of four options, with seven alternatives in items 16 and 18. Each item is scored from 0 to 3 points, with the total score ranging from 0 to 63, with higher scores indicating a higher depressive symptom burden.
Baseline, 3 and 6 months follow-up
Anxiety symptoms
The Generalised Anxiety Disorder Screener (GAD-7) is a 7-item self-report scale used as a screening instrument measuring symptoms of generalized anxiety disorder that has been recommended as brief screening measure for perinatal anxiety. Item scores are summed up to a total score (from 0 to 21 points), with higher scores indicating a higher anxiety symptom burden. There are no cut-off points established for the Spanish version. In the original version, the authors propose a cut-off point of greater than or equal to 10. For the Spanish version, a Cronbach's alpha coefficient of 0.93 was obtained. Considering the 10-point cutoff, sensitivity values of 86.8% and specificity of 93.4% were found.
Baseline, 3 and 6 months follow-up
Secondary Outcomes (4)
Maternal postpartum bonding
Baseline, 3 and 6 months follow-up
Parenting self-regulation
Baseline, 3 and 6 months follow-up
Marital Adjustment
Baseline, 3 and 6 months follow-up
Satisfaction survey
Intervention group participants immediately after completing the WWWT psychoeducative group.
Other Outcomes (9)
Partner Violence
Baseline, 3 and 6 months follow-up
Alcohol use
Baseline, 3 and 6 months follow-up
Childhood trauma
Baseline
- +6 more other outcomes
Study Arms (2)
Usual Care
NO INTERVENTIONParticipants will received the postpartum usual care at the Sexual and Reproductive Health Service (ASSIR).
WWWT psychoeducative intervention
EXPERIMENTALParticipants will received the postpartum routine usual care plus two psychoeducative intervention WWWT sessions at the Sexual and Reproductive Health Service (ASSIR).
Interventions
"What Were We Thinking" (WWWT) is a highly structured, interactive, gender-informed, couples-based, psycho-educational program for parents and a first newborn to promote confident parental caretaking, optimize functioning in the intimate partner relationship and improve infant care manageability. The adaptation of the WWWT programme (Catalan and Spanish version) comprises 2 sessions, each lasting 2 hours, that will be designed for groups of 5-7 families - within the first 6 weeks postpartum -, each consisting of mother, partner (or other caregiver) and their infant(s).
Eligibility Criteria
You may qualify if:
- Primiparous women
- Given birth a healthy, full-term baby in the preceding 2 weeks
- Receiving postpartum healthcare at Atenció a la salut sexual i reproductiva (ASSIR) of Àrea Integral de Salut Barcelona Esquerra (AIS-BE)
- Over 18 years of age
- Give consent to participate in the study
You may not qualify if:
- If are unable to complete the questionnaires due to language or literacy barriers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Alba Rocalead
- Fundació La Marató de TV3collaborator
- Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurinacollaborator
- Universitat Autonoma de Barcelonacollaborator
Study Sites (2)
Unitat de Salut Mental Perinatal (USMP) de l'Hospital Clínic de Barcelona
Barcelona, Barcelona, 08036, Spain
Atenció a la salut sexual i reproductiva (ASSIR) de l'Àrea Integral de Salut Barcelona Esquerra (AIS-BE)
Barcelona, Barcelona, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alba Roca, Doctor
Fundacion Clinic per a la Recerca Biomédica
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
July 15, 2024
First Posted
July 22, 2024
Study Start
November 8, 2024
Primary Completion (Estimated)
June 1, 2027
Study Completion (Estimated)
June 1, 2027
Last Updated
February 26, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share